Machine learning and multi-omics in precision medicine for ME/CFS

Area of Science:

• Biomedical Research
• Computational Biology
• Genetics and Genomics

Background:

• Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) presents diagnostic and treatment challenges due to its complexity and heterogeneity.
• Current diagnostic and therapeutic strategies for ME/CFS are often limited by the absence of validated biomarkers.

Purpose of the Study:

• To review the transformative potential of machine learning and multi-omics in advancing precision medicine for ME/CFS.
• To explore how integrating genomics, transcriptomics, proteomics, and metabolomics can improve ME/CFS research and clinical practice.

Main Methods:

• Overview of machine learning concepts for analyzing large-scale biological datasets.
• Discussion of multi-omics biomarker discovery, data quality, and integration strategies.
• Examination of ME/CFS case studies to illustrate practical applications.

Main Results:

• Machine learning and multi-omics approaches are crucial for identifying novel biomarkers in ME/CFS.
• Effective data integration and quality control are essential for robust multi-omics analysis.
• Case studies demonstrate the feasibility of applying these advanced techniques to ME/CFS.

Conclusions:

• Precision medicine, powered by machine learning and multi-omics, holds significant promise for unraveling the biological intricacies of ME/CFS.
• Future progress necessitates robust computational tools and collaborative data-sharing initiatives.